Efficacy of VIP as Treatment for Bacteria-Induced Keratitis Against Multiple Pseudomonas aeruginosa Strains

Por Carion, Thomas W., McWhirter, Cody R., Grewal, Daiyajot K., Berger, Elizabeth A.
Publicado no Invest Ophthalmol Vis Sci (2015)

VIP protects human retinal microvascular endothelial cells against high glucose-induced increases in TNF-α and enhances RvD1

Por Shi, Haoshen, Carion, Thomas W, Jiang, Youde, Steinle, Jena J, Berger, Elizabeth A
Publicado no Prostaglandins Other Lipid Mediat (2016)

A regulatory role for β-adrenergic receptors regarding the resolvin D1 (RvD1) pathway in the diabetic retina

Por Shi, Haoshen, Carion, Thomas W., Jiang, Youde, Chahine, Adam, Steinle, Jena J., Berger, Elizabeth A.
Publicado no PLoS One (2017)

Functional Analysis of the CpsA Protein of Streptococcus agalactiae

Por Hanson, Brett R., Runft, Donna L., Streeter, Cale, Kumar, Abhin, Carion, Thomas W., Neely, Melody N.
Publicado em 2012

β-adrenergic receptor agonist, Compound 49b, inhibits TLR4 signaling pathway in diabetic retina

Por Berger, Elizabeth A., Carion, Thomas W., Jiang, Youde, Liu, Li, Chahine, Adam, Walker, Robert Jason, Steinle, Jena J.
Publicado no Immunol Cell Biol (2016)